This donation was officially formalised on November 23rd and was announced by Dr. Leonor Beleza, during the latest annual meeting of the Board of Trustees of the Champalimaud Foundation. The announcement took place in the presence of all board members, including Queen Sofia of Spain.
The funding provided by the Würth Group and the non-profit Würth Foundation is intended to support research into pancreatic cancer - a type of malignancy that persists as one of the most lethal, yet remains among the least explored.
The research is spearheaded by Prof. Dr. Markus W. Büchler, a world-renowned physician specialising in pancreatic cancer research and surgery. Junior and senior doctors, alongside scientists, collaborate at the research center to promote crucial breakthroughs in research and empower healthcare professionals worldwide in addressing this formidable disease.
"We are very grateful for the support of the Würth Group and the non-profit Würth Foundation as it paves the way for extensive years of cancer research. This grant will contribute significantly to advancing our efforts and enhance the care provided to patients worldwide", says Leonor Beleza.
